Routine Coronary Atherosclerosis Imaging in the Cardiovascular Risk Assessment of Prediabetes and Diabetes

HomeCirculation: Cardiovascular ImagingVol. 16, No. 10Routine Coronary Atherosclerosis Imaging in the Cardiovascular Risk Assessment of Prediabetes and Diabetes No AccessEditorialRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessEditorialRequest AccessFull TextRoutine Coronary Atherosclerosis Imaging in the Cardiovascular Risk Assessment of Prediabetes and Diabetes Thiago Bosco Mendes and Marcio Sommer Bittencourt Thiago Bosco MendesThiago Bosco Mendes Department of Medicine, University of Pittsburgh Medical Center, PA (T.B.M., M.S.B.). and Marcio Sommer BittencourtMarcio Sommer Bittencourt Correspondence to: Marcio Sommer Bittencourt, MD, MPH, PhD, UPMC Presbyterian Hospital, Suite A-429, 200 Lothrop St, Pittsburgh, PA 15213. Email E-mail Address: [email protected] https://orcid.org/0000-0002-3711-1754 Department of Medicine, University of Pittsburgh Medical Center, PA (T.B.M., M.S.B.). University of Pittsburgh Medical School, PA (M.S.B.). Originally published29 Sep 2023https://doi.org/10.1161/CIRCIMAGING.123.016079Circulation: Cardiovascular Imaging. 2023;16This article is a commentary on the followingCoronary Atherosclerosis Across the Glycemic Spectrum Among Asymptomatic Adults: The Miami Heart Study at Baptist Health South FloridaFootnotesFor Disclosures, see page 805.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to: Marcio Sommer Bittencourt, MD, MPH, PhD, UPMC Presbyterian Hospital, Suite A-429, 200 Lothrop St, Pittsburgh, PA 15213. Email msbittencourt@mail.harvard.eduREFERENCES1. Whiteley L, Padmanabhan S, Hole D, Isles C. Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey.Diabetes Care. 2005; 28:1588–1593. doi: 10.2337/diacare.28.7.1588CrossrefMedlineGoogle Scholar2. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis.Diabet Med. 2009; 26:142–148. doi: 10.1111/j.1464-5491.2008.02640.xCrossrefMedlineGoogle Scholar3. Preis SR, Pencina MJ, Hwang SJ, D'Agostino RB, Savage PJ, Levy D, Fox CS. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study.Circulation. 2009; 120:212–220. doi: 10.1161/CIRCULATIONAHA.108.846519LinkGoogle Scholar4. Raggi P. Screening for atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus: controversies and guidelines.Can J Diabetes. 2020; 44:86–92. doi: 10.1016/j.jcjd.2019.08.009CrossrefMedlineGoogle Scholar5. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Das SR, Hilliard ME, Isaacs D, et al. 10. Cardiovascular disease and risk management: standards of care in diabetes—2023.Diabetes Care. 2023; 46(supplement_1):S158–S190. doi: 10.2337/dc23-S010CrossrefMedlineGoogle Scholar6. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines.Circulation. 2019; 140:e596–e646. doi: 10.1161/CIR.0000000000000678LinkGoogle Scholar7. Muhlestein JB, Lappé DL, Lima JAC, Rosen BD, May HT, Knight S, Bluemke DA, Towner SR, Le V, Bair TL, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.JAMA. 2014; 312:2234–2243. doi: 10.1001/jama.2014.15825CrossrefMedlineGoogle Scholar8. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease.N Engl J Med. 2007; 356:1503–1516. doi: 10.1056/NEJMoa070829CrossrefMedlineGoogle Scholar9. Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, et al; ISCHEMIA Research Group. Initial invasive or conservative strategy for stable coronary disease.N Engl J Med. 2020; 382:1395–1407. doi: 10.1056/NEJMoa1915922CrossrefMedlineGoogle Scholar10. Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, et al; LEADER Steering Committee. Liraglutide and cardiovascular outcomes in type 2 diabetes.N Engl J Med. 2016; 375:311–322. doi: 10.1056/NEJMoa1603827CrossrefMedlineGoogle Scholar11. Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu X-F, Ireland MA, Lenderink T, et al; LoDoCo2 Trial Investigators. Colchicine in patients with chronic coronary disease.N Engl J Med. 2020; 383:1838–1847. doi: 10.1056/NEJMoa2021372CrossrefMedlineGoogle Scholar12. Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, et al; COMPASS Investigators. Rivaroxaban with or without aspirin in stable cardiovascular disease.N Engl J Med. 2017; 377:1319–1330. doi: 10.1056/NEJMoa1709118CrossrefMedlineGoogle Scholar13. Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, et al; REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia.N Engl J Med. 2019; 380:11–22. doi: 10.1056/NEJMoa1812792CrossrefMedlineGoogle Scholar14. Patel KV, Budoff MJ, Valero-Elizondo J, Ali SS, Havistin R, Lakshman S, Blaha MJ, Blankstein R, Shapiro MD, Arias L, et al. Coronary atherosclerosis across the glycemic spectrum among asymptomatic adults: the Miami Heart Study at Baptist Health South Florida.Circ Cardiovasc Imaging. 2023; 16:e015314. doi: 10.1161/CIRCIMAGING.123.015314LinkGoogle Scholar15. Gæde P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes.N Engl J Med. 2008; 358:580–591. doi: 10.1056/nejmoa0706245CrossrefMedlineGoogle Scholar16. Capodanno D, Angiolillo DJ. Aspirin for primary cardiovascular risk prevention and beyond in diabetes mellitus.Circulation. 2016; 134:1579–1594. doi: 10.1161/CIRCULATIONAHA.116.023164LinkGoogle Scholar17. Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects.J Am Coll Cardiol. 2016; 67:2395–2410. doi: 10.1016/j.jacc.2016.02.071CrossrefMedlineGoogle Scholar18. Study Group ACCORD, Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus.N Engl J Med. 2010; 362:1575–1585. doi: 10.1056/NEJMoa1001286CrossrefMedlineGoogle Scholar19. Rawshani A, Rawshani A, Franzén S, Sattar N, Eliasson B, Svensson A-M, Zethelius B, Miftaraj M, McGuire DK, Rosengren A, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.N Engl J Med. 2018; 379:633–644. doi: 10.1056/NEJMoa1800256CrossrefMedlineGoogle Scholar20. Magnussen C, Ojeda FM, et al; Global Cardiovascular Risk Consortium. Global effect of modifiable risk factors on cardiovascular disease and mortality [published online August 26, 2023].N Engl J Med. 2023. doi: 10.1056/NEJMoa2206916. Epub ahead of print. PMID: 37632466.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesCoronary Atherosclerosis Across the Glycemic Spectrum Among Asymptomatic Adults: The Miami Heart Study at Baptist Health South FloridaKershaw V. Patel, et al. Circulation: Cardiovascular Imaging. 2023;16 October 2023Vol 16, Issue 10 Advertisement Article InformationMetrics © 2023 American Heart Association, Inc.https://doi.org/10.1161/CIRCIMAGING.123.016079PMID: 37772410 Originally publishedSeptember 29, 2023 KeywordsEditorialscardiovascular diseasescoronary artery diseaseearly diagnosishumansPDF download Advertisement SubjectsCardiovascular DiseaseDiabetes, Type 2EpidemiologyPrimary PreventionRisk Factors